New Form 8-K - Vor Biopharma Inc. Filed: 2025-07-22 AccNo: 0001193125-25-162644 Size: 289 KB Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers Item 7.01: Regulation FD Disclosure Item 9.01: Financial Statements and Exhibits
Know Labs Reminds its Stockholders to Vote Ahead of the Special Meeting on July 24
INVESTOR ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Replimune
New Form 8-K - CNS Pharmaceuticals, Inc. Filed: 2025-07-22 AccNo: 0001683168-25-005284 Size: 550 KB Item 3.03: Material Modifications to Rights of Security Holders Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year Item 8.01: Other Events Item 9.01: Financial Statements and Exhibits